NOCAP, Inc. – Trademark Portfolio

Entity Type: 03

NOCAP, Inc. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 14 are pending. Notable registered marks include MIRAGE, CAPTIONS, and MIRAGE STUDIO. The owner is based in New York, NY.

169 Madison Ave., STE 11185

New York, NY 10016

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NOCAP, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (10 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (10 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does NOCAP, Inc. have?

NOCAP, Inc. has 20 U.S. trademarks filed with the USPTO. Of these, 6 registered, 14 pending.

What trademark classes does NOCAP, Inc. file in?

NOCAP, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are NOCAP, Inc.'s most well-known trademarks?

NOCAP, Inc.'s registered trademark portfolio includes well-known marks such as MIRAGE, CAPTIONS, and MIRAGE STUDIO. These are among 6 currently registered trademarks in the portfolio.

What is NOCAP, Inc.'s trademark registration success rate?

NOCAP, Inc. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 14 applications are pending review.